CTA
GH icon

Carillon Tower Advisers’s Guardant Health GH Stock Holding History

Carillon Tower Advisers’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$43.2M Buy
+335,487
New +$38.6M 0.26% 118
2020
Q3 		– Sell
-335,487
Closed -$27.2M – 456
2020
Q2 		$27.2M Hold
335,487
– – 0.21% 152
2020
Q1 		$22.4M Hold
335,487
– – 0.22% 161
2019
Q4 		$26.2M Buy
335,487
+180,180
+116% +$13M 0.18% 203
2019
Q3 		$9.91M Buy
+155,307
New +$13.7M 0.07% 332

Other funds holding GH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Carillon Tower Advisers's GH Position: Q4 2020 in Review

Carillon Tower Advisers opened a new position in Guardant Health (GH) in Q4 2020: 335,487 shares worth $43.2M. The stake represents 0.26% of the portfolio and ranks #118 among its holdings. This is a return to the name: Carillon Tower Advisers previously reported a position in GH as recently as Q2 2020.

Carillon Tower Advisers first reported a position in GH in Q3 2019 and has held it in 5 quarters since. 419 funds tracked by Wall St. Rank hold GH as of Q4 2020.

  • Carillon Tower Advisers held 335,487 shares of Guardant Health worth $43.2M as of Q4 2020.
  • Guardant Health was a new Carillon Tower Advisers position in Q4 2020.
  • Guardant Health made up 0.26% of Carillon Tower Advisers's portfolio in Q4 2020, its #118 holding.
  • Carillon Tower Advisers first reported a position in Guardant Health in Q3 2019 and has held it in 5 quarters since.
  • 419 funds tracked by Wall St. Rank held Guardant Health as of Q4 2020.

Based on Carillon Tower Advisers's 13F filing for Q4 2020, filed 12 Feb 2021.